Cellarim Labs
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cellarim Labs - overview
Established
2023
Location
Karnataka, -, India
Primary Industry
Biopolymers
About
Cellarim Labs, based in India, specializes in manufacturing innovative beauty ingredients, including the first cell-free hyaluronic acid, NeuHyal, emphasizing purity and sustainable production methods. Established in 2023 by CEO Nisa Mehreen and CTO Hitesh Rafalia in Karnataka, India, Cellarim Labs focuses on the production of advanced beauty ingredients. In December 2025, Cellarim Labs raised INR 60 million in seed funding co-led by new investors 3i Partners and Venture Catalysts, with participation from new investor Momentum Capital. Cellarim Labs specializes in developing advanced beauty ingredients, prominently featuring NeuHyal, which is India's first cell-free hyaluronic acid.
This product is crafted without microbes, fermentation, or harsh chemicals, ensuring high purity and sustainability. NeuHyal accommodates various formulation requirements with customizable molecular weights for different applications such as hydration and skin absorption. The company also provides a range of clean skincare products, including serums and moisturizers, alongside hygiene items and custom beauty actives, targeting beauty brands and manufacturers globally across North America, Europe, and Asia. Operating through a B2B model, Cellarim Labs generates revenue by supplying high-performance, clean-label active ingredients directly to beauty brands and manufacturers.
The partnerships often involve custom formulations or standard offerings tailored to client needs. Their premium pricing reflects the quality and sustainable nature of their products, catering to both large-scale production and bespoke solutions. In December 2025, Cellarim Labs secured INR 60 million in Seed funding, which will be utilized to establish a pilot-scale biomanufacturing facility, enhance production capabilities, and expand supply to beauty and cosmetic brands. The company is likely to explore new markets and geographic regions to broaden its reach, details of which will be further clarified as they progress.
Current Investors
Venture Catalysts, 3i Partners, Momentum Capital
Primary Industry
Biopolymers
Sub Industries
Biopolymers, Dermatology, Chemicals
Website
www.cellarim.com
Verticals
Clean Technology, Manufacturing, Research (Non-Medical)
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.